Close this search box.
Close this search box.

ERUK, Autistica & Young Epilepsy to commission research study

Epilepsy Research UK (ERUK) is joining forces with Autistica and Young Epilepsy to commission a new study to better understand the prevalence and incidence of epilepsy in autism.

Why is this research important?

People who are autistic and have epilepsy face significant challenges and inequalities. We know that approximately 8.4 million people worldwide have both conditions. On average, autistic people with epilepsy have poor quality of life, poor health and die early. More research is vital to increase our understanding of epilepsy and autism and how the two conditions interact.

The commissioned research will aim to create a dossier outlining the scientific evidence and scale of the issue in human, social and economic terms. This project will highlight potential areas in the field where research is needed, and where strategic or collaborative action can be taken in order to make a real difference to people who are autistic and have epilepsy.

This study builds on ERUK’s 2019 International Expert Workshop on Epilepsy and Neurodevelopmental disorders, which brought together world leading experts and partner organisations, including Autistica and Young Epilepsy. The workshop showcased the latest research and seeded new research ideas and collaborations. The three organisations made epilepsy in autism a research priority, and ERUK has since announced a joint fellowship with Autistica aiming to improve epilepsy treatment for autistic people (read more here), and a joint fellowship with Young Epilepsy, aiming to improve epilepsy treatment for young people (read more here).

The organisations wish to fund the creation of an evidence dossier focusing on:

  1. A literature review of globally published peer-reviewed papers that focus on both autism and epilepsy, from basic/fundamental science to applied, where appropriate.
  2. Synthesis of existing economic analysis of the cost of epilepsy in autistic people/extrapolation from existing sources if the evidence base is limited.
  3. Synthesis of all evidence to create a dossier that is accessible to a wide range of researchers, policymakers, funders and professionals.


Now that the full applications have been received, they will be sent externally for independent peer review. Our Scientific Advisory Committee (SAC) will then rigorously evaluate each application, in accordance with AMRC (Association of Medical Research) and taking into consideration the peer review comments. In the case of the fellowship award, there is also a three–panel interview. Once this process has been completed, the SAC will meet in March to recommend to the Board the highest scoring applicants for funding.

  • Applicants should complete this form and return it via email to Autistica’s Research & Grants Officer, Dr Cat Hughes: [email protected]
  • Proposals are due no later than 1st May 2020 at 11:59 PM local UK time. Autistica reserves the right to return without review any proposals found not to be in compliance with the policies, procedures, and research priorities outlined in the call for proposals.
  • Please pay close attention to the guidance for applicants.


Please read Autistica’s full guidance for applicants.

The grant must be hosted at a UK institution although international collaborations are permitted.

Eligibility must be demonstrated with a letter from your institution which you should submit with the application form.


  • Applications must align with the principles set out in Autisitica’s Research Strategy.
  • Feasibility: You must include a clear and realistic plan to create the Evidence Dossier.
  • Involvement of autistic adults, children and/or families in the design and production of research is viewed positively by Autistica.
  • Please consider Austica’s research network, Discover, as a resource which can facilitate involvement, communications, dissemination and policy outputs.

Share This Post